What is Olio?
Founded in 2018 and headquartered in Indianapolis, Indiana, Olio operates as a specialized digital communication platform designed to optimize the collaborative efforts of health systems and their affiliated provider networks. In an industry often fragmented by siloed data and inefficient communication channels, Olio provides a unified interface that facilitates real-time information exchange regarding patient care. By integrating directly into existing clinical workflows, the platform reduces administrative friction and improves the quality of care transitions. Olio's market position is defined by its focus on the intersection of healthcare IT and operational efficiency, addressing the critical need for scalable, secure, and intuitive tools that support multi-stakeholder engagement in complex medical environments.
How much funding has Olio raised?
Olio has raised a total of $26.9M across 5 funding rounds:
Angel/Seed
$2.5M
Debt
$150K
Debt
$260K
Series A
$13M
Series B
$11M
Angel/Seed (2019): $2.5M, investors not publicly disclosed
Debt (2020): $150K led by PPP
Debt (2021): $260K supported by PPP
Series A (2022): $13M featuring Mutual Capital Partners and Fulcrum Equity Partners
Series B (2025): $11M backed by Mutual Capital Partners and Fulcrum Equity Partners
Key Investors in Olio
Mutual Capital Partners
Mutual Capital Partners is a Cleveland-based venture capital fund that focuses on investing in early-stage software and medical device companies in the Midwest. The firm partners with innovative healthcare startups, providing not just financial support but also guidance and resources to help them succeed.
Fulcrum Equity Partners
Fulcrum Equity Partners provides entrepreneurs with the capital and hands-on support necessary to accelerate their business growth. They invest between $5-35 million in minority and majority growth opportunities, focusing on B2B software and healthcare services.
PPP
Public-Private Partnership
What's next for Olio?
With the successful closure of this latest funding round, Olio is expected to prioritize the expansion of its product suite and the deepening of its market penetration within the United States. The strategic roadmap likely includes enhancing the platform's data analytics capabilities to provide deeper insights into patient outcomes and provider performance. Furthermore, the company is well-positioned to leverage its existing partnerships with institutional investors to explore new market segments, potentially extending its reach into specialized care areas that require high-touch coordination. As the healthcare industry continues to shift toward integrated care models, Olio's role as a digital connective tissue will be pivotal in driving long-term operational success and improving patient-centric outcomes.
See full Olio company page
